HIGHLIGHTS
- who: Gennaro Gadaleta-Caldarola and collaborators from the 5, Barletta, Italy have published the Article: Pemigatinib in Intrahepatic Cholangiocarcinoma: A Work in Progress, in the Journal: (JOURNAL)
- future: The authors specifically focus on the current challenges and future research directions of pemigatinib use in CCA patients.
SUMMARY
Cholangiocarcinoma: A Work in Cholangiocarcinoma (CCA) represents the second most frequent primary liver cancer (PLC) following hepatocellular carcinoma (HCC), accounting for approximately 15% of all PLCs and 3% of gastrointestinal tumors worldwide. Until very recently, combination chemotherapy with cisplatin plus gemcitabine (CisGem) represented the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.